indibaactiv.com Sitesinin İlk 10 Rakibi

indiba.com

FAQs Want to find more about the INDIBA technology? How do the treatments work? Or how to use it with other treatments? The answers to these and more can be found below. General FAQs How does INDIBA therapy work? INDIBA is an electromagnetic current which is delivered to the body via electrodes at a radiofrequency of 448kHz. This current gradually increases the treated tissue temperature. The temperature rise triggers the body’s natural regeneration, repair and defence responses. For the current frequency of 448 kHz other effects can also be obtained without heating the body’s tissues, demonstrated via molecular research; bio-stimulation. Is INDIBA therapy safe? INDIBA is approved by specific country’s regulatory bodies, it is CE marked and FDA approved. INDIBA provides comprehensive training and specialist courses. We are constantly working with leading universities and research centres to ensure we deliver safe and effective technology. Why 448 kHz? INDIBA invests a lot of resources on researching their technology to ensure the best results. During this research, a team at the highly recognized Spanish University Hospital Ramon y Cajal in Madrid (Dr Ubeda and team) have been looking into what happens to the body’s cells when INDIBA is applied. They have found that INDIBA’s 448kHz frequency is effective at stimulating stem cell proliferation and differentiating them. Normal healthy cells are not injured. It was also tested on certain types of cancer cells in vitro, where it was found that it decreased the number of these cells establishing, but not normal cells, so that it was safe to use in humans and, therefore, on animals as well. What are the main biological effects of INDIBA therapy? Depending on the reached temperature, different effects are obtained: At non-heating intensities, due to the effect of the unique 448kHz current, bio-stimulation occurs. This can help in the early stages of an injury by accelerating the body’s action. It can also help with pain re